Crossmark

An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma

Crossref DOI link: https://doi.org/10.1038/s41392-020-00221-8

Published Online: 2020-09-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Chaoqi

Zhang, Guochao

Sun, Nan

Zhang, Zhen

Xue, Liyan

Zhang, Zhihui

Yang, Haijun

Luo, Yuejun

Zheng, Xiaoli

Zhang, Yonglei

Yuan, Yufen

Lei, Ruixue

Yang, Zhaoyang

Zheng, Bo

Wang, Le

Che, Yun

Wang, Feng

Wang, Sihui

Gao, Shugeng

Xue, Qi

Zhang, Yi https://orcid.org/0000-0001-9861-4681
He, Jie https://orcid.org/0000-0002-0285-5403
License Information

Text and Data Mining valid from 2020-09-04

Version of Record valid from 2020-09-04
More Information

Article History

Received: 30 March 2020

Revised: 20 May 2020

Accepted: 4 June 2020

First Online: 4 September 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below